David A. Tulis, PhD - Publications

Physiology East Carolina University, Greenville, NC, United States 

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Holt AW, Martin DN, Shaver PR, Adderley SP, Stone JD, Joshi CN, Francisco JT, Lust RM, Weidner DA, Shewchuk BM, Tulis DA. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation. Cellular Signalling. PMID 27302407 DOI: 10.1016/J.Cellsig.2016.06.012  0.76
2015 Stone JD, Holt AW, Vuncannon JR, Brault JJ, Tulis DA. AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism. American Journal of Physiology. Heart and Circulatory Physiology. 309: H1251-9. PMID 26276823 DOI: 10.1152/Ajpheart.00846.2014  0.76
2013 Johnson TL, Tulis DA, Keeler BE, Virag JA, Lust RM, Clemens S. The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis. Plos One. 8: e74116. PMID 24023697 DOI: 10.1371/Journal.Pone.0074116  0.76
2013 Stone JD, Narine A, Shaver PR, Fox JC, Vuncannon JR, Tulis DA. AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. American Journal of Physiology. Heart and Circulatory Physiology. 304: H369-81. PMID 23203966 DOI: 10.1152/Ajpheart.00446.2012  0.76
2012 Stone JD, Narine A, Tulis DA. Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase. Frontiers in Physiology. 3: 409. PMID 23112775 DOI: 10.3389/Fphys.2012.00409  0.76
2012 Joshi CN, Martin DN, Shaver P, Madamanchi C, Muller-Borer BJ, Tulis DA. Control of vascular smooth muscle cell growth by connexin 43. Frontiers in Physiology. 3: 220. PMID 22737133 DOI: 10.3389/Fphys.2012.00220  0.76
2012 Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, Durante W. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Frontiers in Pharmacology. 3: 48. PMID 22470341 DOI: 10.3389/Fphar.2012.00048  0.76
2012 Adderley SP, Joshi CN, Martin DN, Tulis DA. Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells. Frontiers in Pharmacology. 3: 10. PMID 22347188 DOI: 10.3389/Fphar.2012.00010  0.76
2011 Joshi CN, Martin DN, Fox JC, Mendelev NN, Brown TA, Tulis DA. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. The Journal of Pharmacology and Experimental Therapeutics. 339: 394-402. PMID 21825001 DOI: 10.1124/Jpet.111.183400  0.76
2009 Keswani AN, Peyton KJ, Durante W, Schafer AI, Tulis DA. The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects. Journal of Cardiovascular Pharmacology and Therapeutics. 14: 116-24. PMID 19342499 DOI: 10.1177/1074248409333266  0.76
2009 Mendelev NN, Williams VS, Tulis DA. Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 53: 121-31. PMID 19188837 DOI: 10.1097/Fjc.0B013E31819715C4  0.76
2009 Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, Wang H, Tulis DA, Durante W. Arginase promotes neointima formation in rat injured carotid arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 488-94. PMID 19164802 DOI: 10.1161/Atvbaha.108.183392  0.76
2009 Liu XM, Peyton KJ, Mendelev NN, Wang H, Tulis DA, Durante W. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Molecular Pharmacology. 75: 208-17. PMID 18923065 DOI: 10.1124/Mol.108.048314  0.76
2008 Tulis DA. Novel therapies for cyclic GMP control of vascular smooth muscle growth. American Journal of Therapeutics. 15: 551-64. PMID 19127140 DOI: 10.1097/Mjt.0B013E318140052F  0.76
2007 Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model. Methods in Molecular Medicine. 139: 31-66. PMID 18287663 DOI: 10.1007/978-1-59745-571-8_2  0.76
2007 Tulis DA. Rat carotid artery balloon injury model. Methods in Molecular Medicine. 139: 1-30. PMID 18287662 DOI: 10.1007/978-1-59745-571-8_1  0.76
2007 Mukhopadhyay S, Tulis DA. Endocannabinoid regulation of matrix metalloproteinases: implications in ischemic stroke. Cardiovascular & Hematological Agents in Medicinal Chemistry. 5: 311-8. PMID 17979695 DOI: 10.2174/187152507782109917  0.76
2007 Jackson EB, Mukhopadhyay S, Tulis DA. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside. Current Vascular Pharmacology. 5: 1-14. PMID 17266609 DOI: 10.2174/157016107779317224  0.76
2006 Tulis DA. Methods for identifying cardiovascular agents: a review. Recent Patents On Cardiovascular Drug Discovery. 1: 47-56. PMID 18221073 DOI: 10.2174/157489006775244236  0.76
2006 Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, Rao MN, Tulis DA, Ren J, Sreejayan N. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 85-90. PMID 16239599 DOI: 10.1161/01.Atv.0000191635.00744.B6  0.76
2005 Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cellular and Molecular Biology (Noisy-Le-Grand, France). 51: 441-6. PMID 16309565 DOI: 10.1170/T648  0.76
2005 Masters KS, Lipke EA, Rice EE, Liel MS, Myler HA, Zygourakis C, Tulis DA, West JL. Nitric oxide-generating hydrogels inhibit neointima formation. Journal of Biomaterials Science. Polymer Edition. 16: 659-72. PMID 16001723 DOI: 10.1163/1568562053783722  0.76
2004 Tulis DA. Salutary properties of YC-1 in the cardiovascular and hematological systems. Current Medicinal Chemistry. Cardiovascular and Hematological Agents. 2: 343-59. PMID 15320784 DOI: 10.2174/1568016043356200  0.76
2003 Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation. 107: 98-105. PMID 12515750 DOI: 10.1161/01.Cir.0000047675.86603.Eb  0.76
2002 Yuan Y, Liao L, Tulis DA, Xu J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation. 105: 2653-9. PMID 12045172 DOI: 10.1161/01.Cir.0000018947.95555.65  0.76
2002 Tulis DA, Bohl Masters KS, Lipke EA, Schiesser RL, Evans AJ, Peyton KJ, Durante W, West JL, Schafer AI. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Biochemical and Biophysical Research Communications. 291: 1014-21. PMID 11866467 DOI: 10.1006/Bbrc.2002.6552  0.76
2001 Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 104: 2710-5. PMID 11723024 DOI: 10.1161/Hc4701.099585  0.76
2001 Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 155: 113-22. PMID 11223432 DOI: 10.1016/S0021-9150(00)00552-9  0.76
2000 Tulis DA, Durante W, Peyton KJ, Chapman GB, Evans AJ, Schafer AI. YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochemical and Biophysical Research Communications. 279: 646-52. PMID 11118339 DOI: 10.1006/Bbrc.2000.3942  0.76
2000 Tulis DA, Durante W, Peyton KJ, Chapman GB, Evans AJ, Schäfer AI. YC-1 stimulates vessel wall cgmp and inhibits injuryinduced neointima formation Blood. 96: 36a.  0.76
1998 Tulis DA, Prewitt RL. Medial and endothelial platelet-derived growth factor A chain expression is regulated by in vivo exposure to elevated flow. Journal of Vascular Research. 35: 413-20. PMID 9858866 DOI: 10.1159/000025612  0.76
1998 Tulis DA, Unthank JL, Prewitt RL. Flow-induced arterial remodeling in rat mesenteric vasculature. The American Journal of Physiology. 274: H874-82. PMID 9530199 DOI: 10.1152/Ajpheart.1998.274.3.H874  0.76
Show low-probability matches.